Aqilion, a Swedish biopharma company developing therapies for diseases driven by chronic inflammation and dysregulated immune ...

The treatment is the first and only long-acting HIV prevention option available on the NHS in England and Wales ...

Sanofi has reported that the high-dose formulation of its influenza vaccine, Elfueda (known as Fluzone High-Dose in the US), ...

The study demonstrated strong clinical accuracy in differentiating pancreatic cancer patients from control subjects ...

Pelage Pharmaceuticals, a clinical-stage regenerative medicine biotech, is advancing PP405, its lead candidate for the ...

Inizio is leading the way in Intelligent Commercialization™ by uniting proprietary AI-powered platforms, deep scientific ...

Mission Therapeutics, a clinical-stage biotechnology company, has raised $13.3m to advance the clinical development of its ...

International Patient Engagement Day 2025 has been launched by the International Society for Patient Engagement Professionals ...

Merck has appointed David Weinreich as global head of R&D and chief medical officer of its healthcare business sector. Based ...

Eli Lilly has appointed Peter Marks, former director of the US Food and Drug Administration’s (FDA) Centre for Biologics ...

London’s King’s Cross tunnel has been illuminated in pink for the first time ever, marking Breast Cancer Awareness Month ...

The second phase of Precision Oncology Ireland (POI), the country’s largest cancer research programme has been launched by ...